Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/adjuvant-belzutifan-combo-practice-changing-rcc-2026a10006nc?src=rss
Author :
Publish date : 2026-03-04 09:17:00
Copyright for syndicated content belongs to the linked Source.
